GLP-1 Analogues: Risk of Gallbladder Disease, Not Pancreatitis GLP-1 Analogues: Risk of Gallbladder Disease, Not Pancreatitis

Taking glucagon-like peptide 1 (GLP-1) analogues is associated with an increased risk of bile duct and gallbladder disease, but not pancreatitis, in people with type 2 diabetes, according to two new studies.Reuters Health Information
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Diabetes & Endocrinology News Source Type: news